FDA approves Toujeo(R) Max SoloStar(R)
Max SoloStar holds more insulin than any other long-acting insulin pen
New pen can potentially reduce the number of injections for people who need more long-acting insulin and lower copay costs
BRIDGEWATER, N.J., March 27, 2018 -- (Healthcare Sales &... Biopharmaceuticals, Drug Delivery, FDA Sanofi, Toujeo, insulin glargine, insulin pen, insulin, diabetes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news